Thyroid Hormones May Increase Risk for Cognitive Disorders
Overtreating older patients with the drugs was associated with cognitive disorders, according to a new study.
Source: medscape.com
Medesis Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Medesis Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Medesis Pharma Today - Breaking & Trending Today
Medesis Pharma S A : END OF ENROLLEMENT OF THE 68 PATIENTS IN MEDESIS PHARMA PHASE 2 CLINICAL STUDY OF NANOLITHIUM FOR THE TREATMENT OF ALZHEIMER'S DISEASE -October 17, 2023 at 03:19 am EDT
PRESS RELEASE END OF ENROLLEMENT OF THE 68 PATIENTS IN MEDESIS PHARMA PHASE 2 CLINICAL STUDY OF NANOLITHIUM FOR THE ...
Source: marketscreener.com
MEDESIS PHARMA: FAVORABLE REPORT FROM IDSMB EXPERTS ON THE ONGOING PHASE 2 CLINICAL STUDY ON NANOLITHIUM IN THE TREATMENT OF ALZHEIMER'S DISEASE
PRESS RELEASE MEDESIS PHARMA: FAVORABLE REPORT FROM IDSMB EXPERTS ON THE ONGOING PHASE 2 CLINICAL STUDY ON NANOLITHIUM IN THE TREATMENT OF... | May 23, 2023
Source: marketscreener.com
DelveInsight Business Research LLP: Huntington's Disease Market to Witness Upsurge in Growth at a Tremendous CAGR of 18.4% During the Study Period (2019-2032), Predicts DelveInsight
The growth of the Huntington's disease market is expected to be mainly driven by less competitive scenarios, entry of innovative emerging therapies, rising prevalence, and geriatric population
Source: finanznachrichten.de
Huntington's Disease Market to Witness Upsurge in Growth at a Tremendous CAGR of 18.4% During the Study Period (2019-2032), Predicts DelveInsight
/PRNewswire/ -- DelveInsight's Huntington's Disease Market Insights report includes a comprehensive understanding of current treatment practices, Huntington's...
Source: prnewswire.com